IRIS Accounts Production v24.3.2.46 10234481 Board of Directors 1.10.23 30.9.24 30.9.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh102344812023-09-30102344812024-09-30102344812023-10-012024-09-30102344812022-09-30102344812022-10-012023-09-30102344812023-09-3010234481ns15:EnglandWales2023-10-012024-09-3010234481ns14:PoundSterling2023-10-012024-09-3010234481ns10:Director12023-10-012024-09-3010234481ns10:PrivateLimitedCompanyLtd2023-10-012024-09-3010234481ns10:SmallEntities2023-10-012024-09-3010234481ns10:AuditExempt-NoAccountantsReport2023-10-012024-09-3010234481ns10:SmallCompaniesRegimeForDirectorsReport2023-10-012024-09-3010234481ns10:SmallCompaniesRegimeForAccounts2023-10-012024-09-3010234481ns10:FullAccounts2023-10-012024-09-3010234481ns10:Director22023-10-012024-09-3010234481ns10:RegisteredOffice2023-10-012024-09-3010234481ns5:CurrentFinancialInstruments2024-09-3010234481ns5:CurrentFinancialInstruments2023-09-3010234481ns5:ShareCapital2024-09-3010234481ns5:ShareCapital2023-09-3010234481ns5:RetainedEarningsAccumulatedLosses2024-09-3010234481ns5:RetainedEarningsAccumulatedLosses2023-09-3010234481ns5:ComputerEquipment2023-10-012024-09-3010234481ns5:ComputerEquipment2023-09-3010234481ns5:ComputerEquipment2024-09-3010234481ns5:ComputerEquipment2023-09-3010234481ns5:CostValuation2023-09-3010234481ns5:DisposalsRepaymentsInvestments2024-09-3010234481ns5:CostValuation2024-09-3010234481ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-3010234481ns5:WithinOneYearns5:CurrentFinancialInstruments2023-09-3010234481ns5:Non-currentFinancialInstrumentsns5:AfterOneYear2024-09-3010234481ns5:Non-currentFinancialInstrumentsns5:AfterOneYear2023-09-30
REGISTERED NUMBER: 10234481 (England and Wales)









UNAUDITED CESSATION FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 SEPTEMBER 2024

FOR

META DIAGNOSTICS LTD

META DIAGNOSTICS LTD (REGISTERED NUMBER: 10234481)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


META DIAGNOSTICS LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 30 SEPTEMBER 2024







DIRECTORS: B K Leonard
L Deegan-Riley





REGISTERED OFFICE: 4th Floor Tuition House
27-37 St George's Road
Wimbledon
London
SW19 4EU





REGISTERED NUMBER: 10234481 (England and Wales)





ACCOUNTANTS: Hartley Fowler LLP
Chartered Accountants
4th Floor Tuition House
27-37 St George's Road
Wimbledon
London
SW19 4EU

META DIAGNOSTICS LTD (REGISTERED NUMBER: 10234481)

BALANCE SHEET
30 SEPTEMBER 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 - -
Investments 5 - 15,000
- 15,000

CURRENT ASSETS
Debtors 6 198,092 69,368
Cash at bank 493,430 1,828
691,522 71,196
CREDITORS
Amounts falling due within one year 7 148,447 7,318
NET CURRENT ASSETS 543,075 63,878
TOTAL ASSETS LESS CURRENT
LIABILITIES

543,075

78,878

CAPITAL AND RESERVES
Called up share capital 50,000 50,000
Retained earnings 493,075 28,878
SHAREHOLDERS' FUNDS 543,075 78,878

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 25 March 2025 and were signed on its behalf by:





B K Leonard - Director


META DIAGNOSTICS LTD (REGISTERED NUMBER: 10234481)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024


1. STATUTORY INFORMATION

Meta Diagnostics Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The company has ceased to trade and therefore the going concern basis is not appropriate for the preparation of the financial statements. No adjustments were required to the carrying value of assets and liabilities. Any liabilities which cannot be discharged from the company's assets will be settled by the director.

Preparation of consolidated financial statements
The financial statements contain information about Meta Diagnostics Ltd as an individual company and do not contain consolidated financial information as the parent of a group. The company is exempt under Section 399(2A) of the Companies Act 2006 from the requirements to prepare consolidated financial statements.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 33% on cost

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Financial instruments
Investments in unlisted company shares are measured at cost less accumulated impairment.

Cash at bank is measured at transaction price.

Debtors and creditors with no stated interest rate and receivables or payables within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit or loss account in other
administrative expenses.

Impairment
Assets not measured at fair value are reviewed for any indication that the asset may be impaired at each balance sheet date. If such indication exists, the recoverable amount of the asset, or the asset's cash generating unit, is estimated and compared to the carrying amount. Where the carrying amount exceeds its recoverable amount, an impairment loss is recognised in profit or loss unless the asset is carried at a revalued amount where the impairment loss is a revaluation decrease.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

META DIAGNOSTICS LTD (REGISTERED NUMBER: 10234481)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


2. ACCOUNTING POLICIES - continued

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

4. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1 October 2023 4,555
Additions 2,376
Disposals (6,931 )
At 30 September 2024 -
DEPRECIATION
At 1 October 2023 4,555
Charge for year 792
Eliminated on disposal (5,347 )
At 30 September 2024 -
NET BOOK VALUE
At 30 September 2024 -
At 30 September 2023 -

5. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£   
COST
At 1 October 2023 15,000
Disposals (15,000 )
At 30 September 2024 -
NET BOOK VALUE
At 30 September 2024 -
At 30 September 2023 15,000

META DIAGNOSTICS LTD (REGISTERED NUMBER: 10234481)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2024


6. DEBTORS
2024 2023
£    £   
Amounts falling due within one year:
Amounts owed by group undertakings - 20,322
Other debtors 194,655 42,891
194,655 63,213

Amounts falling due after more than one year:
Other debtors 3,437 6,155

Aggregate amounts 198,092 69,368

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors - 118
Taxation and social security 145,197 -
Other creditors 3,250 7,200
148,447 7,318

8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

At the balance sheet date, the company was owed £193,910 (2023 - £10,589) by a director who has taken the funds in order to continue with the liquidation of the company. The balance is unsecured, has no repayment terms or interest interest.